Summary
The latest Pharmaceutical and Healthcare disease pipeline market research report on “Liver Cirrhosis - Pipeline Review, H1 2018”, provides an overview of the Liver Cirrhosis (Gastrointestinal) pipeline landscape.
Cirrhosis is scarring of the liver caused by many forms of liver diseases and conditions, such as hepatitis and chronic alcohol abuse. The scar tissue damages the normal structure of the liver which affects the normal flow of blood through the liver.
Symptoms of
Liver Cirrhosis:
Loss of
appetite, itchy skin, weight loss, tiredness and weakness and nausea.
Treatment: includes liver
transplant surgery
Highlights
Highlights
·
The pharmaceuticals pipeline guide “Liver Cirrhosis - Pipeline Review, H1
2018”, provides comprehensive information on the therapeutics under development
for Liver Cirrhosis (Gastrointestinal), complete with analysis by stage of
development, drug target, mechanism of action (MoA), route of administration
(RoA) and molecule type.
·
The guide covers the descriptive pharmacological action of
the therapeutics, its complete research and development history and latest news
and press releases.
Liver
Cirrhosis (Gastrointestinal) pipeline guide helps in identifying and tracking
emerging players in the market and their portfolios, enhances decision making
capabilities and helps to create effective counter strategies to gain
competitive advantage.
Request a sample Page:
Scope
· The pipeline
guide provides a snapshot of the global therapeutic landscape of Liver
Cirrhosis.
· The pipeline
guide reviews pipeline therapeutics for Liver Cirrhosis by companies and
universities/research institutes based on information derived from company and
industry-specific sources.
· The pipeline
guide covers pipeline products based on several stages of development ranging
from pre-registration till discovery and undisclosed stages.
· The pipeline
guide features descriptive drug profiles for the pipeline products which
comprise, product description, descriptive licensing and collaboration details,
R&D brief, MoA & other developmental activities.
View Report: http://www.jsbmarketresearch.com/pharmaceuticals/liver-cirrhosis-pipeline-review-h1-2018
Hepatic Encephalopathy - Market Insight, Epidemiology and Market Forecast - 2027
ReplyDeleteThe recent market report on the encephalopathy explains the growth factors and the opportunities to grab in the near future. Know the various competitive segments and much more to explore in the report.
https://goo.gl/JuV5CK